|

Elecoglipron Clinical Trials

5 actively recruiting trials across 3 locations

▲ +4 trials since June 2026

Also known as: Active IMP

Pipeline

Phase 3: 5

Top Sponsors

  • AstraZeneca5

Indications

  • Diabetes5
  • Type 2 Diabetes Mellitus4
  • Type 2 Diabetes With Chronic Kidney Disease1
  • Weight Management1

Birmingham, Alabama3 trials

A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM

Research Site

Phase 3
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus

Research Site

Phase 3
A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus

Research Site

Phase 3

Huntsville, Alabama1 trial

A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus

Research Site

Phase 3

Peoria, Arizona1 trial

A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin

Research Site

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.